Roxicet and Proamatine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Roxicet (acetaminophen; oxycodone hydrochloride) and Proamatine (midodrine hydrochloride). Common drug interactions include cellulitis among females and polyarthritis among males.

The phase IV clinical study analyzes what interactions people have when they take Roxicet and Proamatine. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Roxicet?

Roxicet has active ingredients of acetaminophen; oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 2,254 Roxicet users. Check the latest studies of Roxicet.

What is Proamatine?

Proamatine has active ingredients of midodrine hydrochloride. It is often used in hypotension. eHealthMe is studying from 968 Proamatine users. Check the latest studies of Proamatine.



On Aug, 07, 2026

18 people who take Roxicet and Proamatine together, and have interactions are studied.

Roxicet and Proamatine drug interactions.

What are the common drug interactions of Roxicet and Proamatine, by gender? *:

female:

  1. Cellulitis (infection under the skin)
  2. Coagulopathy (blood's ability to clot is impaired)
  3. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  4. Deafness
  5. Decreased appetite
  6. Dilatation ventricular
  7. Dysgeusia (disorder of the sense of taste)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Ejection fraction decreased (systolic heart failure)
  10. Enterococcus test positive

male:

  1. Polyarthritis (arthritis which involves 5 or more joints simultaneously)
  2. Septic shock (shock due to blood infection)
  3. Arrhythmia (irregular heartbeat)
  4. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  5. Arteriovenous fistula site complication
  6. Arthralgia (joint pain)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Bone disorder
  10. Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)

What are the common drug interactions of Roxicet and Proamatine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Deformity (disfigurement)
  2. Device related infection
  3. Erythema (redness of the skin)
  4. Muscle tightness
  5. Muscular weakness (muscle weakness)
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  8. Oedema peripheral (superficial swelling)
  9. Pain in extremity
  10. Polyarthritis (arthritis which involves 5 or more joints simultaneously)

40-49:

n/a

50-59:

  1. Cellulitis (infection under the skin)
  2. Coagulopathy (blood's ability to clot is impaired)
  3. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  4. Deafness
  5. Decreased appetite
  6. Dilatation ventricular
  7. Dysgeusia (disorder of the sense of taste)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Ejection fraction decreased (systolic heart failure)
  10. Enterococcus test positive

60+:

  1. Abscess neck (neck abscesses)
  2. Addison's disease (addison's disease, a hormonal disorder disease)
  3. Arthralgia (joint pain)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Bone disorder
  7. Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
  8. Breast haematoma (blood-filled swelling in the breast)
  9. Cardiac arrest
  10. Cardiac disorder

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 17 people, 94.44%
  2. Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 17 people, 94.44%
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood): 12 people, 66.67%
  4. Nuclear Magnetic Resonance Imaging Brain: 1 person, 5.56%
  5. Nuclear Magnetic Resonance Imaging Abdominal: 1 person, 5.56%
  6. Kidney Transplant Rejection: 1 person, 5.56%
  7. High Blood Pressure: 1 person, 5.56%
  8. High Blood Cholesterol: 1 person, 5.56%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.56%
  10. Bleeding Disorders: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Roxicet and Proamatine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Roxicet and Proamatine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Roxicet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proamatine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Roxicet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proamatine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; oxycodone hydrochloride and midodrine hydrochloride (the active ingredients of Roxicet and Proamatine, respectively), and Roxicet and Proamatine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: